Certainly, the genotype-independent decrease in CD40 expression by peripheral immune cells in MS is a unique and novel finding, and leads to many questions as to the reasons for this decrease, as well as the subsequent effects. This evidence concerns the gene CD40 and myeloid sarcoma.